Intended for healthcare professionals

Endgames Case Review

An unexpected ECG finding

BMJ 2023; 380 doi: https://doi.org/10.1136/bmj-2022-072333 (Published 02 March 2023) Cite this as: BMJ 2023;380:e072333
  1. Qinghua Chang, attending physician,
  2. Zhaolong Xu, professor,
  3. Ningning Fu, postgraduate student,
  4. Renguang Liu, professor
  1. The Cardiovascular Institute of the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, China
  1. Correspondence to R Liu liurenguanglaoshi{at}126.com

A woman in her 60s presented to hospital for a second cycle of postoperative adjuvant chemotherapy with docetaxel and cyclophosphamide, having received her first cycle 19 days previously. She had received a diagnosis of left breast cancer six weeks earlier, for which she had undergone modified radical mastectomy. She had no other medical history.

Results of cardiac function tests (electrocardiogram (ECG), troponin I, brain natriuretic peptide (BNP), and transthoracic echocardiogram) were in the normal range on all evaluations at the start of her first cycle of chemotherapy. Before starting the second cycle, she underwent an ECG (fig 1) as standard procedure in the oncology clinic. Abnormal findings were seen on the ECG. The patient did not report any chest pain. Repeat troponin I and BNP test results were within normal ranges and repeat transthoracic echocardiogram showed normal biventricular functions with a left ventricular ejection fraction of 62% (no change from before) and no …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription